Clinical outcomes of patients with idiopathic MN according to anti-PLA₂R levels.

<p>MN, membranous nephropathy; Anti-PLA₂R, anti-phospholipase A₂ receptor antibody; N, number of patients.</p>a<p>Group of patients whose serum samples showed anti-PLA₂R reactivity at dilutions of 1∶25 or 1∶100 with negative results at dilutions over 1∶100; ^bGroup of patients whose serum samples showed anti-PLA₂R reactivity at dilutions of 1∶500 or 1∶2000 with negative results at dilutions over 1∶2000; ^cGroup of patients whose serum samples showed anti-PLA₂R reactivity at dilutions up to 1∶8000.